H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NYSE: BHVN) | Delayed: 13.88 -0.81 (5.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.69 | 52 Week High | $ | |||
| Open | $15.22 | 52 Week Low | $ | |||
| Day High | $15.37 | P/E | N/A | |||
| Day Low | $13.83 | EPS | $ | |||
| Volume | 4,693,234 | |||||
